Skip to main content
. 2017 Dec 1;8(70):114736–114745. doi: 10.18632/oncotarget.22827

Figure 1. HSD17B4 is over expressed in adrenocortical carcinoma (ACC).

Figure 1

Reproduction of TCGA ACC dataset showing (A) genetic alteration of a panel of adrenocortical hormone-related genes; (B) expression levels of a panel of adrenocortical hormone-related genes; (C) expression of HSD17B4 and its association with excessive hormonal type; (D) expression level of each gene grouped by the presence of excessive hormone; and (E) difference in overall survival between patients with or without HSD17B4 overexpression.